Cargando…

Development of 2-Methoxyhuprine as Novel Lead for Alzheimer’s Disease Therapy

Tacrine (THA), the first clinically effective acetylcholinesterase (AChE) inhibitor and the first approved drug for the treatment of Alzheimer’s disease (AD), was withdrawn from the market due to its side effects, particularly its hepatotoxicity. Nowadays, THA serves as a valuable scaffold for the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mezeiova, Eva, Korabecny, Jan, Sepsova, Vendula, Hrabinova, Martina, Jost, Petr, Muckova, Lubica, Kucera, Tomas, Dolezal, Rafael, Misik, Jan, Spilovska, Katarina, Pham, Ngoc Lam, Pokrievkova, Lucia, Roh, Jaroslav, Jun, Daniel, Soukup, Ondrej, Kaping, Daniel, Kuca, Kamil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152224/ https://www.ncbi.nlm.nih.gov/pubmed/28788095 http://dx.doi.org/10.3390/molecules22081265

Ejemplares similares

Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation
por: Spilovska, Katarina, et al.
Publicado: (2017)

7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment
por: Korabecny, Jan, et al.
Publicado: (2015)

Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors
por: Svobodova, Barbora, et al.
Publicado: (2019)

A-agents, misleadingly known as “Novichoks”: a narrative review
por: Opravil, Jakub, et al.
Publicado: (2023)

Profiling donepezil template into multipotent hybrids with antioxidant properties
por: Mezeiova, Eva, et al.
Publicado: (2018)

Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods
por: Janockova, Jana, et al.
Publicado: (2018)

Oximes: Inhibitors of Human Recombinant Acetylcholinesterase. A Structure-Activity Relationship (SAR) Study
por: Sepsova, Vendula, et al.
Publicado: (2013)

7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies
por: Spilovska, Katarina, et al.
Publicado: (2013)

Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
por: Chrienova, Zofia, et al.
Publicado: (2022)

Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings
por: Kuca, Kamil, et al.
Publicado: (2018)

Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D(2) 3,4-dihydroquinolin-2(1H)-one Derivatives Related to Aripiprazole
por: Juza, Radomir, et al.
Publicado: (2021)

Synthesis, in vitro screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivators
por: Malinak, David, et al.
Publicado: (2020)

Structure-Guided Design of N-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer’s Disease
por: Svobodova, Barbora, et al.
Publicado: (2023)

Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies
por: Mamun, Abdullah Al, et al.
Publicado: (2021)

The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats—A Comparison with Trimedoxime and the Oxime K203
por: Kassa, Jiri, et al.
Publicado: (2017)

Evaluation of Cholinesterase Activities During in Vivo Intoxication Using an Electrochemical Sensor Strip – Correlation With Intoxication Symptoms
por: Pohanka, Miroslav, et al.
Publicado: (2009)

Preparation of the Pyridinium Salts Differing in the Length of the N-Alkyl Substituent
por: Marek, Jan, et al.
Publicado: (2010)

Is It the Twilight of BACE1 Inhibitors?
por: Hrabinova, Martina, et al.
Publicado: (2021)

Acetylcholinesterase Reactivators (HI-6, Obidoxime, Trimedoxime, K027, K075, K127, K203, K282): Structural Evaluation of Human Serum Albumin Binding and Absorption Kinetics
por: Zemek, Filip, et al.
Publicado: (2013)

Cholinesterase Research
por: Korabecny, Jan, et al.
Publicado: (2021)

Chemical and Biological Threats, Hazard Potential and Countermeasures
por: Soukup, Ondrej, et al.
Publicado: (2022)

Synthesis and Disinfection Effect of the Pyridine-4-aldoxime Based Salts
por: Marek, Jan, et al.
Publicado: (2015)

Pursuing the Complexity of Alzheimer’s Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists
por: Konecny, Jan, et al.
Publicado: (2020)

The benefit of combinations of oximes for the ability of antidotal treatment to counteract sarin-induced brain damage in rats
por: Caisberger, Filip, et al.
Publicado: (2018)

In Vitro and In Silico Acetylcholinesterase Inhibitory Activity of Thalictricavine and Canadine and Their Predicted Penetration across the Blood-Brain Barrier
por: Chlebek, Jakub, et al.
Publicado: (2019)

Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer’s Disease Treatment
por: Schmidt, Monika, et al.
Publicado: (2020)

Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells
por: Hudáčová, Monika, et al.
Publicado: (2021)

Diagnosis of Intoxication by the Organophosphate VX: Comparison Between an Electrochemical Sensor and Ellman´s Photometric Method
por: Pohanka, Miroslav, et al.
Publicado: (2008)

Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy
por: Valis, Martin, et al.
Publicado: (2016)

Donepezil and Rivastigmine: Pharmacokinetic Profile and Brain-targeting After Intramuscular Administration in Rats
por: Karasova, Jana Zdarova, et al.
Publicado: (2020)

In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers
por: Janockova, Jana, et al.
Publicado: (2019)

Synthesis and In Vitro Evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a Cholinesterase Inhibitor with Regard to Alzheimer's Disease Treatment
por: Korabecny, Jan, et al.
Publicado: (2010)

Assessment of Acetylcholinesterase Activity Using Indoxylacetate and Comparison with the Standard Ellman’s Method
por: Pohanka, Miroslav, et al.
Publicado: (2011)

Preparation of Quinolinium Salts Differing in the Length of the Alkyl Side Chain
por: Marek, Jan, et al.
Publicado: (2012)

Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery
por: Honegr, Jan, et al.
Publicado: (2018)

Wide-Antimicrobial Spectrum of Picolinium Salts
por: Salajkova, Sarka, et al.
Publicado: (2020)

Amaryllidaceae Alkaloids of Belladine-Type from Narcissus pseudonarcissus cv. Carlton as New Selective Inhibitors of Butyrylcholinesterase
por: Al Mamun, Abdullah, et al.
Publicado: (2020)

Multi-spectroscopic monitoring of molecular interactions between an amino acid-functionalized ionic liquid and potential anti-Alzheimer's drugs
por: Sharma, Srishti, et al.
Publicado: (2020)

A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase
por: Kuca, Kamil, et al.
Publicado: (2018)

Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment
por: Soukup, Ondrej, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ev09bnejlrk3q8dv85m4npghpq